Recent 8-K filings for CLB
Highest-materiality recent filing
Core Labs cuts Q1 2026 guidance citing Middle East conflict; revenue now $119-123M
- First quarter 2026 revenue guidance revised to $119M-$123M, down from previously issued guidance.
- Operating income ex-items projected at $5.7M-$7.1M; EPS ex-items $0.05-$0.07.
-
Core Lab Q1 revenue $121.8M; GAAP EPS -$0.02, ex-items $0.06
Revenue $121.8M, down 12% sequentially and flat year-over-year.
-
Core Labs cuts Q1 2026 guidance citing Middle East conflict; revenue now $119-123M
First quarter 2026 revenue guidance revised to $119M-$123M, down from previously issued guidance.
-
Core Laboratories corrects Q4/FY2025 tax error; net income down $4.2M, EPS down $0.09
Income tax expense understated by $4.2M in Q4 and FY2025 due to tax reconciliation and fire-related insurance gain timing.
-
Core Lab Q4 rev $138.3M (+7% YoY); ex-items EPS $0.21 (-4%); declares $0.01 dividend
Q4 revenue $138.3M (+7% YoY); GAAP EPS $0.15, ex-items $0.21 (-4% YoY).
-
Core Lab Q2 rev $130.2M (+5% seq, flat YoY); ex-items EPS $0.19; free cash flow $10.4M
Q2 revenue $130.2M (+5% sequentially, flat YoY); GAAP EPS $0.22; ex-items EPS $0.19 (-14% YoY, +33% sequentially).
-
Core Labs Q1 rev $123.6M, ex-items EPS $0.14 down 25% YoY, declares $0.01 dividend
Revenue $123.6M, down 4% sequentially and 5% YoY; GAAP EPS $0.00, ex-items EPS $0.14 (down 25% YoY).
-
Core Lab Q4 revenue $129.2M, EPS $0.15; FY revenue $523.8M up 3%, free cash flow $43.4M up 200%
Q4 2024 revenue $129.2M (down 4% sequentially, up slightly YoY); GAAP EPS $0.15; ex-items EPS $0.22 (down 12% sequentially, up 16% YoY).
-
Core Lab Q3 revenue $134.4M +7% YoY; EPS ex-items $0.25 +14% YoY; net debt reduced
Revenue $134.4M, up 3% sequentially and over 7% year-over-year.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.75 · Median 0.60 · Most common event earnings